Antimicrobial Methods and Compositions

Principal and Founder

Principal and CEO

Marc H. Burel

• Orthopaedic spine surgeon, entrepreneur, and cofounder/board member of multiple successful startup ventures
  
• Founding Partner at K2M (purchased by Stryker) and Electrocore (recently went public, NASDAQ: ECOR).
  

Principal and Chief Scientific Officer

EU

BRI

• Former Vice President of Research and Development at Orthobond
  
• Extensive experience in the covalent attachment of active end groups to various substrates and achieving goals for regulatory approval
  

​MST is rapidly expanding its patent portfolio with two non-provisional and four provisional filings.  Patent protection includes strategies covering the chemistry of surface attachment, methods of attachment, and compositional character of functional molecules for our surface treatments. 

US

CK

Gordon D. Donald, M.D.

Randy Clevenger, Ph.D.

Leadership Team

Intellectual Property

Business Strategies

2 Application

4 Provisional

• Established R&D agreements with five companies that brought Orthobond to a cash flow-positive position
• Veteran of the medical industry with over 25 years of experience in sales, marketing, and management
  

Lubricious Surface Chemistry Methods and Compositions

Cell Signal Enhancement Growth Induction